Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 1/2 1

Status

Terminated 2Completed 2Withdrawn 1

Sponsor Class

INDUSTRY 10NIH 6OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Multiple Myeloma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Laryngeal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Interventional × gossypol acetic acid × Clear all
NCT02697344 2023-12-28

Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma

Mayo Clinic

Phase 1 Completed
10 enrolled
Plasma cell

Multiple Myeloma

NCT01633541 2023-07-20

Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer

University of Michigan Rogel Cancer Center

Phase 2 Completed
55 enrolled 15 charts
Head & Neck

Laryngeal Neoplasms

NCT01003769 2020-06-16

Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia

Mayo Clinic

Phase 1/2 Terminated
5 enrolled 7 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01285635 2016-03-31

A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck

University of Michigan Rogel Cancer Center

Phase 2 Terminated
35 enrolled 12 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00934076 2015-05-08

Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer

University of Alabama at Birmingham

Phase 1 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡